ScinoPharm Taiwan Ltd (1789) — Capital Reinvestment Ratio
ScinoPharm Taiwan Ltd (1789) has a Capital Reinvestment Ratio of 0.42x as of March 2026, meaning it reinvests 0% of its operating cash flow (NT$199.47 Million) in capital expenditures (NT$83.34 Million). Check ScinoPharm Taiwan Ltd (1789) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ScinoPharm Taiwan Ltd Capital Reinvestment Ratio (2007–2025)
This chart tracks ScinoPharm Taiwan Ltd's Capital Reinvestment Ratio across 19 annual periods. For the full cash flow conversion analysis, see ScinoPharm Taiwan Ltd cash flow conversion.
Annual Capital Reinvestment Ratio for ScinoPharm Taiwan Ltd (2007–2025)
Year-by-year Capital Reinvestment Ratio for ScinoPharm Taiwan Ltd from 2007 to 2025. See cash generation quality of ScinoPharm Taiwan Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.49x | NT$597.11 Million | NT$291.29 Million | ▲ +26.9% |
| 2024 | 0.38x | NT$750.91 Million | NT$288.73 Million | ▼ -68.8% |
| 2023 | 1.23x | NT$231.13 Million | NT$284.71 Million | ▲ +281.2% |
| 2022 | 0.32x | NT$773.79 Million | NT$250.04 Million | ▼ -48.7% |
| 2021 | 0.63x | NT$509.82 Million | NT$321.32 Million | ▲ +225.7% |
| 2020 | 0.19x | NT$946.31 Million | NT$183.10 Million | ▲ +44.4% |
| 2019 | 0.13x | NT$788.95 Million | NT$105.70 Million | ▲ +29.9% |
| 2018 | 0.10x | NT$1.23 Billion | NT$127.05 Million | ▼ -75.6% |
| 2017 | 0.42x | NT$971.71 Million | NT$410.93 Million | ▲ +53.6% |
| 2016 | 0.28x | NT$1.67 Billion | NT$458.52 Million | ▼ -56.9% |
| 2015 | 0.64x | NT$1.04 Billion | NT$667.58 Million | ▼ -44.5% |
| 2014 | 1.15x | NT$888.29 Million | NT$1.02 Billion | ▼ -13.0% |
| 2013 | 1.32x | NT$939.47 Million | NT$1.24 Billion | ▲ +47.5% |
| 2012 | 0.90x | NT$981.55 Million | NT$881.19 Million | ▲ +43.4% |
| 2011 | 0.63x | NT$1.29 Billion | NT$810.14 Million | ▲ +141.4% |
| 2010 | 0.26x | NT$1.56 Billion | NT$405.62 Million | ▲ +75.9% |
| 2009 | 0.15x | NT$1.30 Billion | NT$191.28 Million | ▲ +43.4% |
| 2008 | 0.10x | NT$1.41 Billion | NT$144.62 Million | ▼ -37.3% |
| 2007 | 0.16x | NT$504.50 Million | NT$82.74 Million | — |